NASDAQ:NARI
Inari Medical, Inc. Common Stock
- Stock
Last Close
46.30
17/05 20:00
Market Cap
2.66B
Beta: 1.12
Volume Today
833.13K
Avg: 843.53K
PE Ratio
−1,163.86
PFCF: 110.15
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -10.15M - | -1.19M 88.26% | 13.79M 1,256.97% | 9.84M 28.64% | -29.27M 397.43% | -1.64M 94.41% | |
depreciation and amortization | 283K - | 613.52K 116.79% | 1.39M 125.75% | 4.31M 211.05% | 7.12M 65.25% | 10.74M 50.93% | |
deferred income tax | 144K - | 1.30M 799.93% | 4.20M 224.25% | 47K 98.88% | -584K - | ||
stock based compensation | 248K - | 504.80K 103.55% | 3.52M 598.10% | 25.45M 622.13% | 28.67M 12.67% | 40.34M 40.69% | |
change in working capital | -1.52M - | -6.26M 311.80% | -21.17M 238.20% | -14.30M 32.45% | -21.47M 50.13% | 2.64M 112.29% | |
accounts receivables | -2.17M - | -8.95M 313.62% | -16.71M 86.56% | -14.36M 14.04% | -17.03M 18.59% | -11.05M 35.09% | |
inventory | -558K - | -2.87M 415.02% | -6.64M 131.19% | -10.49M 57.86% | -11.69M 11.44% | -7.44M 36.36% | |
accounts payables | 372K - | 1.83M 393.20% | 498K 72.86% | 3.51M 605.62% | 1.14M 67.56% | 344K 69.82% | |
other working capital | 831K - | 3.73M 349.42% | 1.68M 54.94% | 7.04M 318.00% | 6.11M 13.15% | 20.79M 240.20% | |
other non cash items | 106K - | 101.00K 4.71% | 181K 79.20% | 143K 20.99% | 973K 580.42% | -15.57M 1,700.51% | |
net cash provided by operating activities | -10.89M - | -4.94M 54.68% | 1.91M 138.74% | 25.49M 1,232.95% | -13.97M 154.82% | 35.93M 357.14% | |
investments in property plant and equipment | -753K - | -3.14M 317.55% | -5.46M 73.66% | -13.64M 149.91% | -9.95M 27.07% | -6.20M 37.68% | |
acquisitions net | 37.38M - | 185.26M 395.67% | -240.42M 229.77% | ||||
purchases of investments | -49.98M - | -134.38M 168.88% | -497.87M 270.50% | -406.74M 18.30% | |||
sales maturities of investments | 97M - | 312.60M 222.27% | 595.34M 90.45% | ||||
other investing activites | -37.38M - | -185.26M 395.67% | |||||
net cash used for investing activites | -753K - | -3.14M 317.55% | -55.44M 1,663.19% | -51.02M 7.96% | -195.22M 282.61% | -58.02M 70.28% | |
debt repayment | -10.14M - | -30.25M 198.32% | |||||
common stock issued | 127.21K - | 164.36M 129,106.50% | 6.43M 96.09% | 174.40M 2,613.47% | 10.74M 93.84% | ||
common stock repurchased | -25K - | 5.56M 22,332% | 8.42M 51.53% | 9.92M 17.80% | |||
dividends paid | -25K - | ||||||
other financing activites | 26.76M - | 20.24M 24.37% | 10.05M 50.32% | -7.91M 178.70% | -5.68M 28.22% | -19.50M 243.28% | |
net cash used provided by financing activities | 26.76M - | 10.22M 61.79% | 144.12M 1,309.64% | 4.07M 97.17% | 177.14M 4,249.08% | 1.17M 99.34% | |
effect of forex changes on cash | -402K - | -480K 19.40% | -94K 80.42% | ||||
net change in cash | 15.11M - | 2.14M 85.82% | 90.59M 4,126.28% | -21.86M 124.14% | -32.53M 48.78% | -21.01M 35.40% | |
cash at beginning of period | 6.77M - | 21.88M 223.20% | 24.03M 9.79% | 114.62M 377.03% | 92.75M 19.08% | 60.22M 35.07% | |
cash at end of period | 21.88M - | 24.03M 9.79% | 114.62M 377.03% | 92.75M 19.08% | 60.22M 35.07% | 39.21M 34.89% | |
operating cash flow | -10.89M - | -4.94M 54.68% | 1.91M 138.74% | 25.49M 1,232.95% | -13.97M 154.82% | 35.93M 357.14% | |
capital expenditure | -753K - | -3.14M 317.55% | -5.46M 73.66% | -13.64M 149.91% | -9.95M 27.07% | -6.20M 37.68% | |
free cash flow | -11.64M - | -8.08M 30.61% | -3.55M 56.09% | 11.84M 433.74% | -23.92M 302.04% | 29.73M 224.26% |
All numbers in USD (except ratios and percentages)